Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Neurologia - 35(2020), 9 vom: 07. Nov., Seite 699-700 |
| Sprache: |
Englisch |
|---|
| Weiterer Titel: |
Encefalitis anti-NMDA-R secundaria a infección por SARS-CoV-2 |
|---|
| Beteiligte Personen: |
Álvarez Bravo, G [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2494G1JF75 |
|---|
| Anmerkungen: |
Date Completed 19.01.2021 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.nrl.2020.07.013 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314849416 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314849416 | ||
| 003 | DE-627 | ||
| 005 | 20231225153626.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.nrl.2020.07.013 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1049.xml |
| 035 | |a (DE-627)NLM314849416 | ||
| 035 | |a (NLM)32912742 | ||
| 035 | |a (PII)S0213-4853(20)30245-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Álvarez Bravo, G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection |
| 246 | 3 | 3 | |a Encefalitis anti-NMDA-R secundaria a infección por SARS-CoV-2 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.01.2021 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Drug Combinations |2 NLM | |
| 650 | 7 | |a lopinavir-ritonavir drug combination |2 NLM | |
| 650 | 7 | |a Lopinavir |2 NLM | |
| 650 | 7 | |a 2494G1JF75 |2 NLM | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 650 | 7 | |a Ritonavir |2 NLM | |
| 650 | 7 | |a O3J8G9O825 |2 NLM | |
| 700 | 1 | |a Ramió I Torrentà, L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurologia |d 2007 |g 35(2020), 9 vom: 07. Nov., Seite 699-700 |w (DE-627)NLM171204786 |x 2173-5808 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2020 |g number:9 |g day:07 |g month:11 |g pages:699-700 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.nrl.2020.07.013 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2020 |e 9 |b 07 |c 11 |h 699-700 | ||